Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
2022 · Research and Practice in Thrombosis and Haemostasis · 11 citations
https://doi.org/10.1002/rth2.12736
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
472
Citations
12
h-index
16
i10-index
Covadonga Gómez‐Cuervo is an academic researcher from Research Institute Hospital 12 de Octubre. The author has contributed to research in topics: Venous Thromboembolism Diagnosis and Management & Atrial Fibrillation Management and Outcomes & Central Venous Catheters and Hemodialysis. The author has an h-index of 12, co-authored 44 publications.
ORCID: 0000-0003-2294-2229https://doi.org/10.1002/rth2.12736
https://doi.org/10.1016/j.tru.2020.100010
Click to start Chat